Clinical Trial

Oral Carnitine in Heart Failure Patients

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Heart failure is a condition in which the heart is unable to pump blood effectively, leading to symptoms like being more tired, shortness of breath, and swelling in the body. Carnitine is a naturally occurring substance in the body that plays a role in turning fat into energy. This study will determine whether oral L-Carnitine supplementation can improve symptoms, enhance heart function and possibly improve the quality of life in individuals with heart failure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-30.
Status change: Not Yet Recruiting → Recruiting 2026-04-15
Trial Details
NCT Number NCT07201714
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions Heart Failure, Carnitine Deficiency
Enrollment 20 participants
Start Date 2025-11-12
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-20